Business
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress.
About this update from Cellev8 Nutrition Inc.
[{"type":"text","content":"WELLINGTON, FL and HIGHLANDS RANCH, CO / ACCESSWIRE / December 10, 2024 / Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. This collaboration combines Vivos Therapeutics' FDA-cleared oral medical devices for treating moderate to severe OSA in children and adults with Cellev8 Nutrition's proprietary gummy form of nutraceuticals featuring the powerful enzymatic antioxidant, SOD2, designed to mitigate oxidative stress in the body.Addressing a Significant Health ConcernEli Lilly recently estimated that approximately 80 million American adults suffer from sleep apnea. On top of that, an estimated 10 million children also suffer. The prevalence is particularly high among older adults, with up to 32% of individuals over 65 experiencing OSA. Alarmingly, the American Academy of Sleep Medicine (AASM) estimates that as many as 80% of people with OSA are undiagnosed. This underdiagnosis represents a significant public health challenge, as untreated OSA can lead to serious health complications and substantial economic costs.The Complex Relationship Between Sleep Apnea, Oxidative Stress and InflammationThe relationship between sleep apnea and weight is complex and bidirectional:Obesity as a Risk Factor: Obesity is recognized as one of the most important reversible risk factors for obstructive sleep apnea. Studies suggest that obesity is a major factor in 41% of adult OSA cases, including 58% of moderate-to-severe cases.Impact of Weight Loss: Weight loss has been shown to improve sleep apnea severity. A 5-10% reduction in body weight can significantly improve OSA symptoms. Some studies suggest that a 10% weight loss is associated with a 26% reduction in the number of apnea events during sleep.The interplay between weight and sleep apnea underscores the importance of addressing both issues concurrently for effective management and improved health outcomes.Comprehensive, Natural Approach to Health ManagementThis collaboration intends to provide an all-natural, scientifically-backed solution through Cellev8 Nutrition's comprehensive lineup of nutraceutical products. The range includes Inflammation and Recovery, Focus and Memory, and the newly introduced S...